STOCKHOLM, Nov. 21, 2017 /PRNewswire/ -- Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces an order from Sokaogon Medicinal Corporation (SMC) of Mole Lake, Wisconsin. Sokaogon Medicinal Corporation is focused on industrial hemp cultivation for medicinal applications. The order is valued at $232,704 USD (1,948,186 SEK).
Sokaogon Medicinal Corporation is established as an economic corporation of the Sokaogon Chippewa Community. With plans to process and manufacture CBD oil for treatment of epilepsy and other seizure disorders, the facility will deploy Heliospectra E60 series LED lamps with optimized spectra to ensure medicinal grade crop quality and yields.
"Heliospectra offers Sokaogon a robust, durable lighting solution that will withstand the rigors of commercial cultivation," stated Jimmy Landru, Chairman and CEO, Sokaogon Medicinal Corporation."The light quality and uniform distribution to the bottom of the plant canopy are essential for Sokaogon to achieve consistent medicinal profiles that deliver predictable and repeatable treatment results for patients."
The Sokaogon indoor facility includes vegetative and flowering rooms. Designed to drive photosynthesis and optimize growth, the Heliospectra lights will be applied to the complete plant growth and production cycle to ensure whole plant and product purity.
"The industrial hemp industry demands a reliable solution to standardize plant and product quality. Heliospectra has designed and manufactured proven LED lighting solutions that meet and exceed commercial cultivation performance requirements," said Ali Ahmadian, CEO, Heliospectra. "We welcome the opportunity to partner with Sokaogon Medicinal Corporation as the organization builds out a holistic cultivation approach and resource-efficient business model."